The global Oligonucleotide Synthesis Market is forecasted to be worth USD 9.91 Billion by 2027, according to a current analysis by Emergen Research. The rapid growth of the global market for oligonucleotide synthesis can be attributed to the growing demand for advanced therapeutic procedures. Besides, the rising research activities in the pharmaceutical and biotechnology industry is expected to drive the market growth further. Moreover, the increasing applications of synthesized oligonucleotides are also likely to augment the market growth over the forecasted timeline.
The lack of standardized regulations for the safe use of synthesized oligonucleotide is anticipated to hinder the market growth during the forecasted period.

The latest report on the Oligonucleotide Synthesis market offers detailed information about the industry based on the total revenue generated for the forecast period, 2020 - 2027. The comprehensive study performs an in-depth analysis of the Oligonucleotide Synthesis industry and lays immense emphasis on the major driving forces and restraints expected to govern the overall business for the forecast period, 2020 - 2027. Most importantly, researchers assessing the business environment take a closer look at the past and present trends as well as the future prospect to offer business owners, stakeholders and field marketing executives an intellectual understanding of the winning strategies.

Read more@ https://www.emergenresearch.com/industry-report/oligonucleotide-syn...

Key Highlights From The Report

In May 2020, Integrated DNA Technologies , a leading producer of integrated genomics solutions, has announced the opening of a new production facility located in North

Carolina's Research Triangle Park. The plant extends the production capacity of IDT and will provide the east section of the United States with industry-leading turnaround times for its product range. Integrated DNA

Technologies also planned the North Carolina plant for the first development of goods in response to the COVID-19 epidemic to aid its clients' activities related to COVID-19 analysis and testing.

In the forecast timeframe, the research segment is anticipated to dominate the market with CAGR of 13.0%. The increase in the number of genome research projects undertaken by academic research institutes facilitated the dominant market position in this segment.

The largest market is expected to be held by the hospital segment. The high number of inpatient and outpatient hospitalizations combined with the growing requirement for oligonucleotide drugs drives the market growth in the segment to meet the needs of the vast number of people suffering from chronic diseases.

North America is forecasted to be the largest market over the forecast timeframe, mainly due to the growing research & development activities and the increasing amount of oligos-based diagnoses and treatments being approved by food and drug administration.

Key participants include GeneDesign, Inc., Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc., Bio-Synthesis, Inc., Agilent Technologies, Inc., Biogen Idec International GmbH, Nitto Denko Avecia, Inc., ATDBio Ltd, Integrated DNA Technologies, Inc., and GenScript, Inc. among others.

Request For Free Sample@ https://www.emergenresearch.com/request-sample/351

Product Outlook (Revenue, USD Billion; 2017-2027)
Linkers
Synthesized Oligonucleotides
Equipment
Probe
Adaptor
Reagent

Application Outlook (Revenue, USD Billion; 2017-2027)
Therapeutic
Research
Diagnostics

End-Use Outlook (Revenue, USD Billion; 2017-2027)
Pharmaceutical
Hospitals
Biotechnology
Laboratories
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA

Table of Content

Chapter 1. Methodology & Sources

1.1. Oligonucleotide Synthesis Market Definition
1.2. Oligonucleotide Synthesis Market Research Scope
1.3. Oligonucleotide Synthesis Market Methodology
1.4. Oligonucleotide Synthesis Market Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Oligonucleotide Synthesis Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Oligonucleotide Synthesis MarketSegmentation & Impact Analysis

Continued…